The Women’s Health research Collaborative (WHrC) announces the launch of a multi-stakeholder initiative designed to raise awareness and address the burden of women’s health issues through patient-centered research. Key stakeholders include health systems, advocacy groups, life science organizations, payers, employers, and consumer facing technology organizations who are contributing their influence to activate change within the health care system and society.
WHrC’s first area of focus is Heavy Menstrual Bleeding (HMB) and its association with iron deficiency and iron deficiency anemia. The clinical subcommittee representing providers from UCLA, Texas Children’s Hospital, Nationwide Children’s, Versiti Blood Center, University of Rochester and other influential international health systems. A recent publication by steering committee member Toby Richards, MD highlights the importance of recognizing and managing iron deficiency here.
“Heavy menstrual bleeding and its correlation to ID/IDA impacts more than health. While HMB is the first women’s health need we will address, it is only just the beginning,” says Malcolm Munro, MD and Chair of WHrC’s Steering Committee.
WHrC will expand topics and stakeholder involvement as new initiatives are identified. WHrC has engaged The Kinetix Group (TKG), a healthcare consultancy as its operational partner. “We are proud to have been selected as a partner of choice with WHrC. Organizationally we are aligned to WHrC’s mission of empowering women around healthcare decisions and developing a multi-stakeholder approach to the adoption of evidence based guidelines,” says John Strapp, Co-Founder of TKG.
